Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.
about
Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseBlood-cerebrospinal fluid barrier permeability in Alzheimer's diseaseAnti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesIdentification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammationCerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infectionIntrathecal IgG synthesis: a resistant and valuable target for future multiple sclerosis treatmentsOverview of Albumin and Its Purification MethodsRaltegravir cerebrospinal fluid concentrations in HIV-1 infectionDiagnostic value of paraclinical tests in multiple sclerosis: relative sensitivities and specificities for reclassification according to the Poser committee criteria.Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?: A 18F-FDG PET/CT study.Mild forms of herpes encephalitis.Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus reportCerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.Zinc concentrations in the cerebrospinal fluid of normal adults and patients with neurological diseasesZinc and copper in multiple sclerosis.Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.Uric acid as a CNS antioxidantCerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.Oculomotor dysfunction in patients with syphilis.ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects.Plasminogen in cerebrospinal fluid originates from circulating blood.Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus.Neuropsychiatric Symptoms in LupusSecondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100BCimetidine, but not oxmetidine, penetrates into the cerebrospinal fluid after a single intravenous dose.Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.No detectable concentrations of oxmetidine but measurable concentrations of cimetidine in cerebrospinal fluid (CSF) during multiple dose treatment.Intra-blood-brain barrier synthesis of human immunodeficiency virus antigen and antibody in humans and chimpanzees.Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpesvirus serology in patients with Guillain-Barré syndrome.Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementiaIgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study.Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot studyBiomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapyRevisiting the dilution factor as vital parameter for sensitivity of ELISA assay in CSF and Plasma.
P2860
Q24622136-0143CB76-3958-4CBD-98C4-F4EBF2985A07Q24631720-04FA05EB-C07E-4B23-B6D3-D69E686A5919Q24642126-23785FAD-F02D-4EFA-A5B3-F0D912C99089Q24644706-616784F5-0FBD-4C5D-AFCA-83FF48E94332Q24810504-F531591E-503B-4591-9643-FA660DA22D84Q26851694-8CC905C7-8D9D-413E-9E90-86EDF5ADC8C5Q28468555-83C30066-0BD7-4E0F-A4DC-2B8197BE7F3AQ28476050-54B2AF66-32A5-4531-9DAD-43F65F22A39FQ30495739-EFA74806-BF9A-4DBF-AE8D-8674B90EE7BDQ30651551-AD7265A1-E31F-41CF-8DD5-C2B8E449B459Q33590585-26CDAF7A-009C-472C-AA9C-5D77E1ADAAE2Q33595086-19B66C0A-E9B0-4E39-B4CF-346F62A197CEQ33620497-C180BB8A-382A-4515-88EA-86016640CEFCQ33657728-3A0815D5-92DA-4D0B-85D1-0F5F21DE97BDQ33721681-BC0015D5-ED81-40F6-BD8A-B57DDCAA53ABQ33732864-389FE1EE-A823-403B-884E-CE43200658EEQ33755963-E07CEAC7-1E82-4060-A434-F9F97C78E4E0Q33755968-D3F9A8A5-26FC-472C-9A7E-42C1488C43BDQ33765429-08D43804-315D-490F-9AC8-5C12371F6C25Q33808567-07C2D225-67FC-4ADD-A591-46196A162F89Q33912628-09CE075C-BDDC-4316-A2EB-8C87BE0B8CADQ33931127-D8003B3C-B87F-4E9C-9560-171E1B95204DQ34202181-D2177A9B-40DA-4281-8F3C-F0E2ABC89208Q34235404-06FBC597-1A77-43F6-8096-8E55A3B5AB0DQ34374733-09F7B1A4-E2B7-4915-8BB6-112596789337Q34459628-3364F4BC-8C41-4795-B0FA-A6D4E84819D7Q34462980-50FB9CE7-8FE4-4E86-9B9D-FF9281A4C86EQ34511465-1CE7DBC9-6F0F-4B0A-9450-B59622551208Q34515198-E0CE55E6-A44E-4190-B5D0-9E9667CC9D11Q34621218-E9D23B18-74E6-44BC-8AEB-7DB586150F40Q34628871-F23EF443-F2C8-4CFA-9BF7-B50BB750D434Q34635400-EF54342B-02CC-46C2-B447-212E970AB288Q34746995-6C48E2AD-A6C6-4289-BD13-5AE331BBB890Q34764938-323F6350-9FA0-4A62-80A1-AA4990A995C4Q35025257-778F9CBC-7BA2-4B01-87CF-EA3E752F8C2AQ35052651-4CF323F5-3EB6-474D-A250-CD49E7DD3831Q35093695-731A036F-1DF8-4A05-AA8B-7315D91D3D47Q35226116-1E645E0F-4BC3-4E8F-973C-E1FD93DFF588Q35532868-D4E7957E-310E-4638-B9B3-B039AF77801FQ35540822-E132A378-2E3C-4677-B16B-27EFB44F2292
P2860
Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Principles of albumin and IgG ...... blishment of reference values.
@en
type
label
Principles of albumin and IgG ...... blishment of reference values.
@en
prefLabel
Principles of albumin and IgG ...... blishment of reference values.
@en
P2093
P1476
Principles of albumin and IgG ...... blishment of reference values.
@en
P2093
P304
P356
10.1080/00365517709091496
P577
1977-09-01T00:00:00Z